Hui Ran

549 total citations
21 papers, 370 citations indexed

About

Hui Ran is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Biomedical Engineering. According to data from OpenAlex, Hui Ran has authored 21 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Biomedical Engineering. Recurrent topics in Hui Ran's work include Nanoplatforms for cancer theranostics (5 papers), Photodynamic Therapy Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hui Ran is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Photodynamic Therapy Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hui Ran collaborates with scholars based in China and United States. Hui Ran's co-authors include Ruyuan Deng, Qi Zhang, Qing Su, Qing Su, Ai-Qing Ma, Xuemei Tong, Lanlan Liu, Lei Hu, Jie Zhong and Yemin Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Scientific Reports.

In The Last Decade

Hui Ran

17 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Ran China	10	182	92	87	40	35	21	370
Jia Wu China	12	223 1.2×	66 0.7×	33 0.4×	29 0.7×	50 1.4×	36	451
Qiuping Huang China	13	219 1.2×	137 1.5×	61 0.7×	23 0.6×	12 0.3×	26	476
Shuqin Zhou China	11	152 0.8×	55 0.6×	24 0.3×	37 0.9×	12 0.3×	26	364
Xueming Zhang China	11	170 0.9×	67 0.7×	22 0.3×	83 2.1×	22 0.6×	23	405
Zhenan Ling China	8	228 1.3×	102 1.1×	22 0.3×	41 1.0×	13 0.4×	11	383
Hongyan Su China	8	157 0.9×	35 0.4×	135 1.6×	35 0.9×	15 0.4×	8	432
Chunxian Piao South Korea	15	270 1.5×	62 0.7×	94 1.1×	9 0.2×	24 0.7×	19	478
Luyang Cheng China	14	216 1.2×	68 0.7×	31 0.4×	15 0.4×	23 0.7×	28	393
Tushuai Li China	11	152 0.8×	45 0.5×	34 0.4×	21 0.5×	17 0.5×	23	319

Countries citing papers authored by Hui Ran

Since Specialization

Citations

This map shows the geographic impact of Hui Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ran more than expected).

Fields of papers citing papers by Hui Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ran. The network helps show where Hui Ran may publish in the future.

Co-authorship network of co-authors of Hui Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Ran. A scholar is included among the top collaborators of Hui Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Ran. Hui Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Yicheng, Hong Wang, Hui Ran, et al.. (2025). Engineered Probiotics Remodel the Tumor Immune Microenvironment. ACS Nano. 19(45). 39303–39319.

Ran, Hui, Qiuyue Hu, Yao Lu, et al.. (2025). Impaired efferocytosis by monocytes and monocyte-derived macrophages in patients with poorly controlled type 2 diabetes. World Journal of Diabetes. 16(5). 101473–101473.

Li, Yanbo, Qin Li, Xiaoyong Li, et al.. (2025). Association between lipid profiles and platelet indices in middle-aged and older Chinese: a population-based cross-sectional study. BMC Cardiovascular Disorders. 25(1). 447–447.

Ran, Hui, Lijuan Zhang, Yan Wang, et al.. (2025). A randomized controlled trial of graded exercise rehabilitation enhances diaphragm function and exercise tolerance in patients with AECOPD. Scientific Reports. 15(1). 28510–28510. 1 indexed citations

Ran, Hui, et al.. (2025). Effects of exercise on psychological distress in patients with COPD: A systematic review and meta-analysis of randomised controlled trials. Medicine. 104(34). e44026–e44026.

Ran, Hui, Ye Yang, Weijing Han, et al.. (2024). Programmable ultrasound-mediated swarms manipulation of bacteria–red blood cell microrobots for tumor-specific thrombosis and robust photothermal therapy. Trends in biotechnology. 43(4). 868–892. 5 indexed citations

He, Huamei, Ai-Qing Ma, Jian Ren, et al.. (2023). Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy. SHILAP Revista de lepidopterología. 4(5). 3 indexed citations

Zhang, Lishan, Xiaoting Zhang, Hui Ran, et al.. (2023). A NIR-driven green affording-oxygen microrobot for targeted photodynamic therapy of tumors. Nanoscale. 16(2). 635–644. 8 indexed citations

Zhang, Lishan, Baozhen Zhang, Ruijing Liang, et al.. (2023). A Dual-Biomineralized Yeast Micro-/Nanorobot with Self-Driving Penetration for Gastritis Therapy and Motility Recovery. ACS Nano. 17(7). 6410–6422. 33 indexed citations

10.

Hu, Qiuyue, Yixin Niu, Yao Lu, et al.. (2022). Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice. Frontiers in Pharmacology. 12. 795483–795483. 38 indexed citations

11.

Huang, Dazhi, Yixin Niu, Weiwei Zhang, et al.. (2022). OPG is associated with thyroid nodule development in type 2 diabetes. Journal of Clinical Laboratory Analysis. 36(9). e24615–e24615. 2 indexed citations

12.

Ma, Ai-Qing, Hui Ran, Jiaxing Wang, et al.. (2022). An Urchin-Shaped Copper-Based Metalloporphyrin Nanosystem as a Sonosensitizer for Sonodynamic Therapy. Nanomaterials. 12(2). 209–209. 12 indexed citations

13.

Yin, Ting, Baozhen Zhang, Chong Yan, et al.. (2022). Cancer-macrophage hybrid membrane-camouflaged photochlor for enhanced sonodynamic therapy against triple-negative breast cancer. Nano Research. 15(5). 4224–4232. 21 indexed citations

14.

Ye, Shu, Hui Ran, Hongmei Zhang, et al.. (2021). Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals. Diabetes Metabolic Syndrome and Obesity. Volume 14. 497–504. 7 indexed citations

15.

Yin, Ting, Hui Ran, Yaguang Ren, et al.. (2021). Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition. Biomaterials Science. 10(1). 294–305. 30 indexed citations

16.

Ran, Hui, Yao Lu, Qi Zhang, et al.. (2020). MondoA Is Required for Normal Myogenesis and Regulation of the Skeletal Muscle Glycogen Content in Mice. Diabetes & Metabolism Journal. 45(3). 439–451. 9 indexed citations

17.

Ran, Hui, Yemin Zhu, Ruyuan Deng, et al.. (2018). Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. Journal of Experimental & Clinical Cancer Research. 37(1). 54–54. 91 indexed citations

18.

Deng, Ruyuan, Huo Wu, Hui Ran, et al.. (2017). Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(5). 1065–1074. 31 indexed citations

19.

Deng, Ruyuan, Fengbo Mo, Bowen Chang, et al.. (2017). Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade. Oncotarget. 8(61). 104216–104226. 41 indexed citations

20.

Ran, Hui, et al.. (2014). [A pedigree study of a patient with primary pigmented nodular adrenocortical disease and familial gene mutation].. PubMed. 53(5). 398–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact